These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33474987)

  • 1. Clinical Impact of FDG PET/CT of the Lower Extremities in Patients With Merkel Cell Carcinoma With Primary Disease Site Outside of the Lower Extremities.
    Ishiyama M; Behnia F; Vesselle H
    AJR Am J Roentgenol; 2021 Mar; 216(3):776-780. PubMed ID: 33474987
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical value of whole body
    Bower N; Morris A; O'Connor J; Sponagle M; Bahr R; Gilbert R; Mohamed A; Bower J
    J Med Imaging Radiat Sci; 2024 Jun; 55(2):212-220. PubMed ID: 38403520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of clinical impact of
    Liu J; Larcos G; Howle J; Veness M
    Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
    Iagaru A; Quon A; McDougall IR; Gambhir SS
    Mol Imaging Biol; 2006; 8(4):212-7. PubMed ID: 16724293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
    Kawata S; Imaizumi M; Kako Y; Oku N
    Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Mahajan S; Barker CA; Mauguen A; D'Angelo SP; Yeh R; Pandit-Taskar N
    J Nucl Med; 2022 Jun; 63(6):906-911. PubMed ID: 34620729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.
    Concannon R; Larcos GS; Veness M
    J Am Acad Dermatol; 2010 Jan; 62(1):76-84. PubMed ID: 20082888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
    Ben-Haim S; Garkaby J; Primashvili N; Goshen E; Shapira R; Davidson T; Israel O; Epelbaum R
    Nucl Med Commun; 2016 Aug; 37(8):865-73. PubMed ID: 27092665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution.
    George A; Girault S; Testard A; Delva R; Soulié P; Couturier OF; Morel O
    Nucl Med Commun; 2014 Mar; 35(3):282-90. PubMed ID: 24240193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.
    Ibrahim SF; Ahronowitz I; McCalmont TH; Hernandez Pampaloni M; Ryan JL; Yu SS
    Dermatol Surg; 2013 Sep; 39(9):1323-33. PubMed ID: 23777452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03.
    Poulsen M; Macfarlane D; Veness M; Estall V; Hruby G; Kumar M; Pullar A; Tripcony L; Rischin D
    J Med Imaging Radiat Oncol; 2018 Jun; 62(3):412-419. PubMed ID: 29405630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab.
    Eshghi N; Lundeen TF; MacKinnon L; Avery R; Kuo PH
    Clin Nucl Med; 2018 May; 43(5):e142-e144. PubMed ID: 29538029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance.
    Yao M; Smith RB; Hoffman HT; Funk GF; Graham MM; Buatti JM
    Am J Clin Oncol; 2005 Apr; 28(2):205-10. PubMed ID: 15803018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous Merkel cell carcinoma: role of 18FDG PET-CT].
    Amal G; Sara T; Ghofrane CS; Malika AI; Majdouline H; Souha S; Abdelatif B; Najoua T; Ghita B; Zineb B; Nabil C
    Pan Afr Med J; 2016; 23():156. PubMed ID: 27303574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center.
    Hawryluk EB; O'Regan KN; Sheehy N; Guo Y; Dorosario A; Sakellis CG; Jacene HA; Wang LC
    J Am Acad Dermatol; 2013 Apr; 68(4):592-599. PubMed ID: 23127473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline ultrasound and FDG-PET/CT imaging in Merkel cell carcinoma.
    Zijlker LP; Bakker M; van der Hiel B; Bruining A; Klop WMC; Zuur CL; Wouters MWJM; van Akkooi ACJ
    J Surg Oncol; 2023 Apr; 127(5):841-847. PubMed ID: 36573839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of
    Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
    Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scan.
    Golan H; Volkov O; Linchinsky O; Melloul M
    Nucl Med Rev Cent East Eur; 2005; 8(2):135-6. PubMed ID: 16437401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.